Fecal calprotectin in patients with liver cirrhosis.
Dinesh JothimaniRamya ParamasivamMullaiezhili ManoharanHemalatha RamachandranSubha MuthusamyEvangeline SimonJinesh RavichandranMohamed RelaPublished in: Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology (2023)
FCAL levels are increased in patients with chronic liver disease, with highest level in ACLF. An FCAL level of ≥ 200 µg/g was associated with sepsis and mortality in cirrhotic patients. Larger studies are required to identify the role of FCAL in these patients. Early identification and initiation of anti-microbials may mitigate sepsis and reduce mortality.